Renalytix Plc (NASDAQ:RNLX) Q2 2023 Earnings Call Transcript - Yahoo Finance
2023-04-06 • Google News
Renalytix AI (RNLX)
US$ 0.830.56%
Price Chart
Key Statistics
Market Cap
$ 22.55M
P/E Ratio
0.00
Revenue (TTM)
$ 2.29M
Volume
211.22K
52W High
$ 0.50
52W Low
$ 0.12
Dividend Yield
0.00%
Beta
2.10
Technicals
50-Day MA
0.2695
200-Day MA
0.5102
52 Week High
0.4982
52 Week Low
0.12
About RNLX
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence.
Employees
N/A
Headquarters
New York, NY
CEO
Mr. James R. McCullough M.B.A.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg